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PKR is an interferon-inducible, double-stranded (ds) RNA-activated serine/threonine
protein kinase, and has been shown to play roles in viral pathogenesis, cell growth and
apoptosis. We expressed PKR as a fusion protein with enhanced jellyfish green fluorescence
protein (EGFP) in human embryonic kidney 293 cells to visualize the effect of PKR
transfection. The EGFP-fusion construct with wild-type PKR showed both auto- and
substrate-phosphorylation activities independent of dsRNA, indicating EGFP-PKR is
constitutively active. The EGFP-construct with a mutant PKR with the first RNA binding
domain deleted still possessed kinase activities. On the other hand, the EGFP-fusion with
a catalytically inactive mutant of PKR with the substitution of K at 296 with R, which has
been shown to have tumorigenic properties, did not possess kinase activities. Transfection
of the constitutive active forms of EGFP-PKR constructs induced apoptosis in 293 cells
without dsRNA, whereas the EGFP-fusion with the catalytically inactive mutant did not
cause apoptosis but rather protected cells from Fas-induced cell death. In addition,
Fas-stimulation increased endogenous PKR activities. These results constitute evidence
that PKR is sufficient to induce apoptosis, and plays a role in Fas-mediated apoptosis.
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The interferon-inducible, double-stranded (ds) RNA-ac-
tivated protein kinase (PKR) is a serine/threonine kinase
ubiquitously expressed in mammalian cells (1, 2). Human
PKR consists of 551 amino acids, as deduced from its cDNA
sequence (3), and is divided into two domains; a regulatory
domain in the N-terminal half and a catalytic domain in the
C-tenninal half (4). Two RNA binding domains (RBD)
exist in the regulatory domain, and multiple conserved
catalytic subdomains characteristic of serine/threonine
kinase are located in the catalytic domain (3). PKR is
activated by binding to a variety of dsRNA molecules
generated during viral infection or by polyanions (2). Upon
activation, PKR exhibits two kinase reactions: autophos-
phorylation of itself, and phosphorylation of substrates
which include eukaryotic translational initiation factor 2
(eEF-2ff) (5), transcription inhibition factor IxB (6), and
human immunodeficiency virus-encoded tat protein (7).
Phosphorylation of elF-2a inhibits protein synthesis at the
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initiation level, thereby inhibiting cell growth or viral
replication (4). Thus PKR is thought to participate in the
antiviral and antiproliferative actions of interferon (2, 8).
It was found that the expression of a catalytically inactive
mutant of PKR with the substitution of K at 296 with R or
a mutant with the RNA-binding domain deleted confers
transformation phenotypes upon NIH-3T3 cells, suggesting
that PKR functions as a tumor suppresser (9-11). How-
ever, the mechanisms by which PKR acts as a tumor
suppresser remain to be clarified. Transgenic mice devoid
of PKR activity have been generated, but tumors did not
spontaneously arise (12), arguing against PKR being a
tumor suppresser. On the other hand, PKR overexpression
inhibits the growth of yeast cells (13), and induces apopto-
sis of HeLa cells (14, 15). Recent studies have shown that
transfection of a vector carrying either an antisense PKR or
a trans-dominant negative PKR protected U937 and
NIH-3T3 cells from TNF-a- or serum deprivation-induced
apoptosis (16, 17). Moreover, mouse embryo fibroblasts
derived from mutant mice carrying homozygous deletions
in the PKR gene were revealed to be resistant to apoptosis
in response to double-stranded RNA, TNF-« or lipopoly-
saccharide (IS). These results imply that PKR is involved
in stress-induced apoptosis.
Fas (APO-1/CD95) is a transmembrane protein and
belongs to the nerve growth factor receptor/tumor necrosis
factor receptor superfamily (19, 20). The Fas ligand has
been cloned and the predicted amino acid sequence re-
vealed it also belongs to the tumor necrosis factor family
(21). It is beheved to play an essential role in T cell deletion
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during tolerance. Upon binding of the Fas ligand or agonis-
tic anti-Fas antibodies, Fas undergoes trimerization and
induces a cytolytic signal in the cells (22). The activated
Fas binds to FADD/MORTl through its death domain in
the cytoplasmic region (23, 24), and then FADD/MORTl
binds to FLICE/MACH/Mch5 through the death effector
domain in their N-terminal region (25, 26), which then
activates the downstream caspase cascade (27).
We have suggested that PKR is involved in the induction
of Fas expression by influenza virus infection, since a
synthetic dsRNA, poly(I)-poly(C), similarly increased the
amount of Fas mRNA (28). In addition, the expression of a
dominant negative PKR mutant inhibited the augmented
expression of Fas as well as apoptosis induced by the virus
infection (29). As the basal level of expression of Fas was
still observed in the cells transfected with the dominant
negative PKR mutant, it seems that PKR plays a role not
only in Fas expression but in apoptotic signaling after the
virus infection. However, little is known about the relation-
ship between Fas signaling and PKR activation. In the
present study, we examined the ability of PKR to induce
apoptosis in response to Fas activation, and found that PKR
appears to mediate apoptotic signaling in the Fas pathway.
MATERIALS AND METHODS
Cell Culture and DNA TYansfection—Human embryonic
kidney 293 (293) and COS-1 cells were cultured in Dulbec-
co's modified Eagle's medium (D.MEM) supplemented
with 10% fetal bovine serum, and were maintained under
5% CO2 at 37°C. Cells were transfected with 2//g of
plasmid DNA per 5 X 105 cells using 6 tA of Lipofectamine-
plus and 4//I of Lipofectamine (GibcoBRL, MD, USA)
according to the manufacturer's instructions. For micro-
scopic observation, cells were reseeded on celldesk (Sumi-
tomo Bakelite, Japan) in 24-well plates the day after trans-
fection, and then incubated in the presence or absence of
anti-Fas monoclonal antibodies for another 2 or 3 days. The
cells were then mounted on a slide glass, and the expression
of enhanced jellyfish green fluorescence protein (EGFP)
was observed and photographed under a fluorescence mi-
croscope (Olympus BX-60, Tokyo) at a magnification of 70.
Antibodies—Anti-human Fas monoclonal antibodies
were purchased from Pharmingen (DX2) (San Diego, USA)
or MBL (UB2) (Nagoya). Anti-human PKR monoclonal
antibodies was generously provided by Dr. Ara Hovanes-
sian (Institut Pasteur, France). Anti-human PKR poly-
clonal antibodies (K-17) and anti-GFP polyclonal anti-
bodies were from Santa Cruz Biotechnology (Santa Cruz,
USA) and Clontech Laboratories (Palo Alto, USA), respec-
tively.
Plasmids—Human PKR cDNA subcloned into the pBlue-
script vector (Stratagene, La Jolla, USA) was obtained
from Dr. Ara Hovanessian. A mutant PKR cDNA carrying
a point mutation of K at 296 to R was constructed as
described (29). A mutant PKR that lacks the N-terminal
region (amino acids 1-97) was constructed by deleting the
Scal-Ncol fragment from the PKR cDNA. A mutant PKR
that lacks the N-terminal region (amino acids 1-97) but
contains the leucine zipper motif derived from the tran-
scription factor of NFIL6 (amino acids 303-345) was
constructed as follows. The DNA fragment containing the
leucine zipper motif was obtained by PCR with forward (5'
AAAAGCTTCCTGGAGCTCACGGCCGAGA3') and re-
verse primers (5'AACCATGGGGCGAGCAGGGGCTCG-
GGCAG3') using NFIL6 cDNA (30) as a template. The
amplified DNA fragment was digested with HindUI and
Ncol, and then used to replace the HindUI-Ncol fragment
of wild PKR cDNA. That the HindUl-Ncol fragment was
replaced was verified by DNA sequencing. Wild or mutant
PKR cDNA was digested with HindO! and Xbal, and then
subcloned into the multicloning site of the pEGFP-C3
vector (Clontech Laboratories, Palo Alto, USA) to fuse
EGFP to the N-terminus of each PKR construct. The
resulting EGFP-PKR fusion proteins contained an addi-
tional 16-amino acid sequence derived from the multiclon-
ing site of the vector.
In Vitro PKR Assay—PKR activity was measured with
minor modifications as described (31). Briefly, PKR in a cell
extract was precipitated by incubation with the anti-PKR
monoclonal antibodies or anti-GFP polyclonal antibodies,
followed by protein-G Sepharose 4FF (Pharmacia LKB
Biotechnology, Sweden). The immunoprecipitated PKR
was incubated with [y-32P]ATP (650 Ci/mmol, ICN
Biomedicals, Irvine, California) in the presence or absence
of poly (I)-poly (C) at a concentration of 0.1 //g/ml for 15
min at 30°C, and then with 2 jxg of histone H2A (Boehringer
Mannheim, Germany), which is an effective substrate for
PKR (31), for another 15 min at 30*C. The phosphorylation
reaction was resolved by SDS-PAGE and visualized by
autor adiography.
DNA Fragmentation Assay—DNA was extracted as
described (32). Briefly, cells were rinsed twice with PBS
and then scraped from the dishes. The cell pellets were
resuspended at a density of 2 X10" cells/ml in lysis buffer
consisting of 10 mM Tris-HCl (pH 7.5), 10 mM EDTA, and
0.2% Triton X-100. After 10 min on ice, the lysates were
centrifuged at 15,000 rpm for 10 min, and the supernatants
were extracted with phenol/chloroform and chloroform.
After ethanol precipitation and washing with 70% ethanol,
the DNA was resuspended in TE (10 mM Tris-HCl, pH 8,1
mM EDTA). The samples were then treated with RNase A
(0.6 mg/ml) at 37°C for 30 min, and electrophoresed on a
1.6% agarose gel. After electrophoresis, the gel was stained
with ethidium bromide and photographed.
Immunoblot Analysis—Cells were lysed in lysis buffer
(33). After heating for 3 min at 100°C, the lysates were
resolved by SDS-PAGE, and then transferred to Immo-
bilon-P membranes (Millipore, MA, USA). The blots were
probed with anti-PKR monoclonal or polyclonal antibodies
at a dilution of 1:1,000, and then the secondary anti-mouse
or anti-rabbit immunoglobulin antibodies, respectively,
labeled with horseradish peroxidase at a dilution of 1:
1,000. Signals were visualized with ECL (Amersham,
Buckinghamshire, UK).
RESULTS
Expression of EGFP-PKR Fusion Proteins—High, level
expression of wild-type PKR by transfection is not usually
possible, probably due to generalized inhibition of protein
synthesis. Therefore, ectopic expression of wild-type PKR
is mediated by either recombinant vaccinia virus (14), or
co-transfection of GFP (17). Moreover, endogenous PKR is
superimposed on exogenously transfected PKR of the same
species when analyzed by Western blotting, so it seems to
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be difficult to determine the amount of exogenous PKR. To
overcome these problems, we have constructed and ex-
pressed PKR as a fusion protein with EGFP in cells (Fig. 1).
EGFP was fused with wild-type PKR (designated as PKR),
or with a mutant PKR in which 296K was replaced by R
(designated as K/R). This mutant has been shown to be
I RBD RBD
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Fig. 1. Schematic representation of the various expression
constructs of EGFP-PKR. A schematic representation of human
PKE is presented at the top of the figure. The two RNA binding
domains are denoted as RBD. EGFP is the enhanced jellyfish green
fluorescence protein. PKR denotes the EGFP-fusion with wild-type
PKR. K/R denotes the EGFP-fusion with the mutant PKR containing
the amino acid substitution of K at 296 to R. dN denotes the
EGFP-fusion with the mutant PKR, with the 97 N-terminal amino
acids deleted, indicated as a dotted line. LZ denotes the EGFP-fusion
with the mutant PKR containing the same deletion as dN but with the
leucine zipper motif of NFIL6, which is denoted as LZ. The hatched
box after EGFP denotes the amino acid stretch derived from the
multicloning sites of the vectors.
(A) ^
] EGFP-fusion
dominant negative, and to transform NIH3T3 ceDs upon
transfection (9, 10). EGFP was also fused with a mutant
PKR with the N-terminal region (amino acids 1-97) includ-
ing the first RNA-binding domain (designated as dN)
deleted. This mutant has also been shown to be tumorigenic
(11). The EGFP fusion designated as LZ has a mutant PKR
with the N-terminal region deleted as dN, but retains the
leucine zipper motif of NFIL6 (amino acids 303-345) (30).
PKR has been suggested to undergo dimeraation when it is
activated by dsRNA. Since the leucine zipper motif acts to
form homodimers, LZ could become constitutively active
on dimerization without dsRNA. Expression of these
EGFP-PKR fusion proteins could be easily detected on
(A)
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Fig. 2. Expression of the EGFP-PKR fusion constructs in 293
(A) or COS-1 (B) cells. Cells were transfected with 2
 Mg of each
plasmid construct as indicated above the lanes, using Lipofectamine
reagents according to the manufacturer's instructions. Cells were
lysed in lysis buffer 48 h after transfection. The lysates were then
resolved by SDS-PAGE and transferred to Immobilon-P membranes.
The blots were probed with anti-PKR polyclonal antibodies (Santa
Cruz K-17), followed by anti-rabbit immunoglobulin antibodies
labeled with horseradish peroxidase. Signals were visualized with
ECL. EGFP-fusion indicates the various positions of EGFP-PKR
proteins. PKR indicates the endogenous PKR.
Fig. 3. In vitro kinase activity of EGFP-PKR fusion proteins.
The EGFP-PKR fusion proteins in aliquots of the lame lysates of 293
(A and C) or COS-1 (B) cells as those used in Fig. 2 were immuno-
precipitated with anti-PKR monoclonal antibodies (A and B) or
anti-GFP polyclonal antibodies (Clontech) (C), followed by protein-G
Sepharose 4FF. The immunoprecipitated PKR was incubated with
[y-"P]ATP in the presence ( + ) or absence ( - ) of poly(I)-poly(C), as
indicated above the lanes, at a concentration of 0.1 ^g/ml for 15 min
at 30"C, and then with 2 ^ g of histone H2A for another 15 min at
30'C. The phosphorylation reaction was resolved by SDS-PAGE and
visualized by autoradiography. EGFP-fusion indicates the various
positions of EGFP-PKR proteins. PKR indicates the endogenous PKR.
H2A indicates the histone H2A. In (C), the upper panel shows an
autoradiogram obtained on long exposure for 17 h at room tempera-
ture, while the lower panel shows one on short exposure for 7.5 h at
room temperature of the same gel.
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either fluorescent microscopy or Western blotting because
of their larger molecular weights than that of endogenous
PKR.
The expression of the EGFP-wild or a mutant PKR fusion
protein in 293 or COS-1 cells was examined by Western
blotting using anti-PKR polyclonal antibodies raised
against a peptide corresponding to amino acids 521-537 of
human PKR (Fig. 2, A andB). As expected, PKR was poorly
expressed in these cells (the relative intensity of EGFP-
PKR expressed as a ratio to the endogenous PKR in 293
cells was 0.23, as determined by scanning the film),
whereas a significant amount of K/R was observed (8.0 in
293 cells) (Fig. 2). This seems to be consistent with a







Fig. 4. Expression of the EGFP-
PKR fusion constructs in 293
cells. Cells were transfected with
plasmid constructs as indicated. The
cells were reseeded on celldesk
(Sumitomo Bakelite) in 24-well
plates the day after transfection and
then incubated for another 2 days in
the presence (a-Fas) or absence ( —)
of anti-Fas monoclonal antibodies
(Pharmingen) at 300ng/ml. The
cells were then mounted on a slide
glass and then photographed under a
fluorescence microscope (Olympus)
at a magnification of 70. The pictures
of PKR and dN were overexposed to
visualize the expression of these
constructs.
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were overexpressed in COS-1 cells (34). dN and LZ were
poorly or moderately expressed in COS-1 (0.38 and 0.72,
respectively) or 293 cells (1.18 and 1.61, respectively)
(Fig. 2, A and B), suggesting that dN and LZ have some
kinase activities. The amount of endogenous PKR did not
significantly change on transfection of these constructs
(Fig. 2). To determine whether or not these EGFP fusions
have enzyme activities, the auto- and substrate phosphor -
ylation activities of PKR in the same extracts as used for
the immunoblotting were assayed. Since the anti-PKR
polyclonal antibodies used for immunoblotting was not
suitable for the immunoprecipitation of PKR followed by
the kinase reaction, anti-PKR monoclonal antibodies which
recognizes the N-terminal region was first employed (31).
In the control EGFP-transfected 293 cells, endogenous
PKR activity was effectively stimulated upon poly(I)-poly-
(C) addition, which caused autophosphorylation (3.0-fold
activation) and phosphorylation of histone H2A (4.0-fold
activation) as a substrate (Fig. 3A). EGFP-PKR caused
significant autophosphorylation and histone H2A phosphor-
ylation without poly (I)-poly (C) addition, whereas in K/
R-transfected cells, the activities of both K/R and endo-
genous PKR were similar to that of a control without
poly(I) -poly(C). Moreover, endogenous PKR in K/R-trans-
fected cells was not activated by poly (I) -poly (C), indicating
that K/R dominant-negatively suppresses endogenous
PKR activities in vitro. Since the anti-PKR monoclonal
antibodies did not precipitate endogenous PKR of COS-1
cells, an effect of endogenous PKR on the kinase reaction of
EGFP-PKR constructs could be eliminated (Fig. 3B). PKR
showed both auto- and H2A-phosphorylation activities
independent of poly (I)-poly (C), although they were much
lower than those in 293 cells (Fig. 3B). K/R did not show
any kinase activities in an extract of COS-1 cells, in
contrast to that in 293 cells. These results suggested that
the significant activation of PKR and slight activities of K/
R in 293 cells are due to the effect of endogenous PKR. This
seems to be consistent with the previous report that PKR
itself is a good substrate of PKR (35). To examine mutants
that lack the N-terminal region, dN or LZ was immuno-
precipitated with anti-GFP polyclonal antibodies, and then
kinase activities were assayed (Fig. 3C). dN and LZ exhibit
auto- and substrate phosphorylation activities independent
of poly(I)-poly(C). The relative intensities of autophos-
phorylation of dN and LZ without poly (I)-poly (C) were 2.0
and 1.7, respectively, compared with that of PKR, while the
relative expression levels of dN and LZ were 5.1 and 7.0
compared to that of PKR, respectively (Fig. 2A). Therefore
these mutants may have roughly half to one-third the
enzyme activity of wild-type PKR. Since endogenous and
exogenous PKR molecules exist simultaneously in the
cytosol of PKR-transfected cells, the kinase activities
observed in the extract of 293 cells seem to reflect the
actual activities of EGFP-PKR fusion constructs. Thus, the
EGFP tag may make PKR constructs, except K/R, con-
stitutively active when transfected into 293 cells, while K/
R still retained a dominant negative character, at least in
vitro.
Induction of Apoptosis by EGFP-PKR Fusion Proteins—
The effect of an EGFP-PKR fusion construct on the death of
293 cells was next examined. The expression of an EGFP
fusion was easily detected on fluorescence microscopy (Fig.
4), and the numbers of cells exhibiting the characteristic
morphological changes of apoptosis, i.e. shrinkage and
rounding, were determined in several fields (Fig. 5A).
While EGFP-transfected control cells did not show remark-
able cell rounding or shrinkage (about 18% in Fig. 5A),
many cells underwent apparent apoptosis (about 80%) in
the presence of anti-Fas antibodies. In contrast to the
controls, only a small number of PKR-, dN-, or LZ-trans-
fected cells were fluorescence positive, with much lower
intensity than that in control cells, which was consistent










Fig. 5. The effect of EGFP-PKR fusion constructs on the death
of 293 cells. (A) Cells were transfected with plasmid constructs, as
indicated, and then photographed as described in Fig. 4. The number
of fluorescent cells was determined in several photographs. Shrunken
and rounded cells were scored as apoptotic, and their ratio to the total
fluorescent cells was determined. The values are the means for three
independent experiments. (B and C) Cells were transfected with
plasmid constructs, as indicated above the lanes, and then cultured in
the absence (B) or presence (C) of anti-Fas monoclonal antibodies
(Pharmingen) at a concentration of 300 ng/ml for 36 h. Then chromo-
some DNA was prepared by phenol/chloroform extraction followed
by ethanol precipitation. The DNA samples were treated with
RNaseA and then electrophoresed on a 1.6% agarose gel. After
electrophoresis, the gel was stained with ethidium bromide and
photographed. Lanes M indicate the 100-bp ladder marker.
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that the pictures of PKR and LZ were overexposed to
visualize the expression of these constructs (Fig. 4). In
addition, more than 50% of fluorescence positive cells
exhibited shrinkage and rounding even in the absence of
anti-Fas antibodies (about 56, 65, and 56% of PKR-, dN-,
and LZ-transfected cells, respectively), and most cells
underwent apoptosis in the presence of the antibodies
(about 94, 93, and 82% of PKK-, dN-, and LZ-transfected
cells, respectively). On the other hand, the number of K/R
positive cells was almost the same as that of control ones,
with a significant level of intensity, and fewer K/R-trans-
fected cells showed apoptotic changes, even in the presence
of anti-Fas antibodies (about 11 and 28% in the absence and
presence of anti-Fas antibodies, respectively). To further
determine whether or not the above morphological changes
were due to apoptosis, the fragmentation of chromosomal
DNA into oligomers, another apoptotic marker, was ex-
amined. As shown in Fig. 5B, transfection of PKR, dN, or
LZ into 293 cells caused characteristic DNA fragmentation,
indicating that the above morphological changes were due
to apoptosis, whereas that of EGFP alone or K/R did not. In
addition, transfection of K/R reduced the degree of DNA
fragmentation induced by anti-Fas antibodies. Transfec-
tion of the constructs used in this study into 293 cells did
not alter Fas expression on the cell surface, which was
analyzed by flowcytometry (data not shown). This indicated
that the effect of EGFP-PKR constructs on apoptosis in
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Fig. 6. PKR activity in cells after exposure to anti-Fas mono-
clonal antibodies. (A) 293 cells were cultured for 12 h in the
presence of agonistic anti-Fas monoclonal antibodies (Pharmingen) at
various concentrations, as indicated above the lanes, and then lysates
were prepared, and the in vitro auto- (PKE) and substrate (H2A)
phosphorylation activities were determined in the presence ( + ) or
absence ( —) of poly (I)-poly (C) at 0.1 //g/ml, as described in Fig. 3.
An autoradiograph after 12 h exposure at room temperature is shown.
(B) 293 cells were cultured for 12 h in the presence or absence ( —) of
control anti-Fas monoclonal antibodies (UB2, MBL) at a concentra-
tion of 300 ng/ml. Then lysates were prepared and PKR activities
were determined in the presence of poly(l)-poly(C) at 0.1 jig/ml. An
autoradiograph after 16 h exposure at room temperature is shown.
Portion of the same lysates was subjected to immunoblotting analysis
with anti-PKR monoclonal antibodies (lower panel).
Fas Stimulation Activates PKR—We finally examined
whether the Fas activation stimulates endogenous PKR
activity or not. Extracts of 293 cells were prepared 12 h
after cultivation in the presence of various amounts of
anti-Fas antibodies, and then PKR activities were assayed
(Fig. 6A). Anti-Fas antibodies at a concentration of 300 ng/
ml or more increased the auto- and substrate phosphoryla-
tion activities of PKR, while the total amount of PKR did
not change, as judged on immunoblotting (Fig. 6A). Control
anti-Fas antibodies (UB2), which does not induce apopto-
sis, did not alter the PKR activities or amounts (Fig. 6B),
suggesting that PKR activation is specific to the apoptosis
signal in response to Fas.
DISCUSSION
So far, PKR or a mutant form of it has been expressed as a
fusion protein with TrpE, glutathione S-transferase (GST),
or Gal4 in either Escherichia coli or yeast cells (6, 36, 37).
We expressed PKR as a fusion protein with EGFP. As GFP
does not appear to interfere with cell growth or function
(38), we consider that the effect of an EGFP-PKR construct
on cell growth is due to the PKR structure. As shown
previously, the kinase activity of recombinant GST-PKR
purified from E. coli did not depend on dsRNA (6, 37).
Similarly, EGFP-PKR phosphorylates itself and H2A in a
dsRNA-independent manner. Moreover, the EGFP-fusion
with the mutant PKR with the first RBD deleted, which has
been shown to abrogate the RNA binding ability and to have
tumorigenic properties (11), also showed the kinase active
phenotype independent of dsRNA. A previous study show-
ed that although the PKR mutant with the first RBD deleted
loses the dsRNA response, it is still active in the presence
of a very high dose of dsRNA or an other polyanion such as
heparin (11). Since, native GFP was shown to self-associate
into dimers (39), the EGFP-tag may help an EGFP-PKR
fusion to associate and dimerize, which results in activation
of the fusion construct even in the absence of the first RBD
in the N-terminal region. The LZ motif was thus revealed
to be unnecessary for the dimerization of PKR in an EGFP-
fusion construct.
PKR has been implicated in the apoptosis induced by
TNF-ff, poly (I)-poly (C), interferon, lipopolysaccharide,
and Fas (this study). Consistent with previous reports (14,
17), we showed that the kinase active forms of EGFP-PKR
constructs (PKR, dN, and LZ) are sufficient to induce
apoptosis in 293 cells, whereas a kinase inactive mutant
(K/R) is not able to induce it, indicating that enzyme
activity is necessary for the induction of apoptosis. A recent
study suggested that PKR-induced apoptosis is mediated
through eIF2ar phosphorylation, since forced expression of
a nonphosphorylated mutant of eIF2a protected cells from
apoptosis in response to TNF-o1, whereas a mutant which
mimics phosphorylated eEF2a- is able to induce apoptosis
by itself (17). On the other hand, apoptosis due to infection
by recombinant vaccinia virus carrying wild-type PKR was
completely inhibited on coinfection of recombinant vaccinia
virus expressing bcl-2 without preventing translational
inhibition (40). This suggests that bcl-2 is downstream of
eIF2a in the apoptotic pathway.
The interleukin- l/?-converting enzyme (ICE)-related
cysteine protease family (caspases) is essential in many
kinds of apoptosis (27) including the Fas and TNF-a-
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signaling pathways (22), and caspase-3-activated DNase
(CAD) has been shown to mediate Fas-induced DNA
fragmentation (41). PKR overexpression induces DNA
fragmentation, and has been shown to cause cleavage of one
of the death substrates, PARP (40), which caspase-3 is able
to cleave (42, 43). Therefore, PKR seems to activate
caspase-3-like proteases. On the other hand, caspase-3
seems not to be essential for apoptotic morphological
changes, since a peptide inhibitor for caspase-3 or an
inhibitor of CAD (ICAD) did not inhibit the apoptotic
morphological changes (44). PKR transfection causes
apoptotic morphological changes as well as DNA fragmen-
tation, suggesting that not only caspase-3-like proteases
but also other caspases are involved in PKR-induced
apoptosis.
PKR thus seems to be a general transducer of apoptosis.
However, it remains to be determined what mechanism(s)
increases PKR activities in response to Fas stimulation
even in the absence of a viral infection, and how PKR causes
downstream apoptotic changes. It has been shown that
members of the MAP kinase superfamily, e.g. c-Jun N-
terminal kinase/stress-activated protein kinase (JNK/
SAPK) and p38, are activated in the Fas signaling pathway,
with some relation to caspases (45-47). To answer the
above questions, it is important to determine whether PKR
has some linkage to the JNK/SAPK and p38 pathways or
not. Our EGFP-PKR fusion system may be a useful tool for
such a study.
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